share_log

3 No-Brainer Stocks to Buy With $300 Right Now

3 No-Brainer Stocks to Buy With $300 Right Now

用300美元現在買入的3只不用動腦子的股票
The Motley Fool ·  07/24 16:00
big

Investing in shares can help you build wealth in the long term, although it comes with inherent risks. Nonetheless, some stocks are considered âno-brainersâ due to their fundamentally strong business models, solid financials, and potential for long-term growth. These companies have demonstrated resilience and adaptability in all market conditions, making them ideal choices for long-term investors.

投資股票可以幫助你長期穩健地積累財富,儘管這種投資方式存在固有風險。然而,一些股票由於其基本健康的商業模式、堅實的財務基礎以及長期增長的潛力被認爲是“毫無腦子”的選擇。這些公司在所有市場環境下均表現出抗壓性和適應性,是長期投資者的理想選擇。

So, if you plan to invest in stocks with $300, here are three no-brainer Canadian stocks to consider.

所以,如果你打算以300美元的價格投資股票,這裏有三個毫無腦子的加拿大股票可供選擇。

No-brainer stock #1

毫無疑問的股票#1

Speaking of no-brainer stocks, investors could consider investing in goeasy (TSX:GSY) for its solid financials and long-term growth potential. This financial services company is an industry leader in Canadaâs non-prime lending sector. What stands out is that goeasy has consistently grown its revenue and earnings per share (EPS) at a solid double-digit rate, which has driven its share price and dividend distributions.

說到“毫無腦子”的股票,投資者可以考慮在goeasy(tsx:gsy)投資,因爲它具有堅實的財務基礎和長期增長的潛力。這家金融服務公司是加拿大次級貸款行業的領導者。它的優秀之處在於,goeasy已經以穩定的兩位數速度增長收入和每股收益,推動了其股價和分紅派息。

goeasyâs top line sports a compound annual growth rate (CAGR) of 20% in the last five years. At the same time, its EPS increased at a CAGR of 32.2%. Thanks to its stellar financials, goeasy stock has grown at a CAGR of nearly 34% in the last five years, delivering capital gains of about 332%. Moreover, it enhanced its shareholdersâ returns via higher dividend payments during the same time.

在過去五年中,goeasy的銷售額複合年增長率(CAGR)爲20%。同時,其每股收益以32.2%的CAGR增長。由於其傑出的財務狀況,goeasy股票在過去五年中以近34%的CAGR增長,實現了約332%的資本增值。此外,它通過更高的股息支付提高了股東回報。

The momentum in goeasyâs business is likely to sustain in the coming years, driven by a large addressable market, omnichannel offerings, geographical expansion, and wide product range. These factors will drive goeasyâs loans and overall revenues. Further, the companyâs solid credit underwriting capabilities and focus on operating efficiency will likely cushion its earnings and dividend payments.

goeasy業務的勢頭有望在未來幾年持續,受到大量可尋址市場、全渠道產品、地理擴張和寬廣產品範圍的推動。這些因素將推動goeasy的貸款和整體收入增長。此外,該公司堅實的信貸承銷能力和專注於運營效率將緩衝其收益和分紅派息。

Despite the uptrend in goeasy stock, it is still trading at the next 12-month (NTM) price-to-earnings multiple of 11.2, which is attractive given its higher EPS growth and a decent yield of 2.3%.

儘管goeasy股票處於上漲趨勢,但它仍然以未來12個月(NTM)市盈率11.2的水平交易,這是有吸引力的,因爲它具有更高的每股收益增長和2.3%的可觀收益率。

No-brainer stock #2

毫無疑問的股票#2

WELL Health (TSX:WELL) is a leading digital healthcare company and the largest owner-operator of outpatient medical clinics in Canada. The company is growing rapidly and delivering solid financials. Moreover, WELL stock is trading cheap on the valuation front, providing an excellent opportunity for investing.

WELL Health(tsx:WELL)是一家領先的數字醫療保健公司,也是加拿大最大的門診醫療診所的所有者和運營商。該公司正在快速增長並提供堅實的財務基礎。此外,WELL股票在估值方面交易廉價,爲投資提供了絕佳機會。

The momentum in WELL Healthâs business will likely continue in 2024 and beyond, driven by higher omnichannel patient visits. Moreover, its focus on accretive acquisitions will likely accelerate its growth. Additionally, WELL Health is optimizing operations to enhance organic growth and profitability. By prioritizing capital-efficient growth opportunities, the company aims to leverage its cash flows to reduce debt and limit share issuance.

WELL Health業務的勢頭將在2024年及以後可能會繼續推動,受益於更多的全渠道病人就診。此外,其專注於增長的資產收購將加速其增長。此外,WELL Health正在進行運營優化,以提高有機增長和盈利能力。通過優先考慮資本效率的增長機會,該公司旨在利用其現金流降低債務並限制股份發行。

In Canada, WELL Health is set to strengthen its market leadership as the nationâs first pan-Canadian clinical network. Further, it has implemented a cost optimization program to enhance operational efficiency and profitability. Furthermore, WELL Health is investing in artificial intelligence (AI) technologies to develop new products that will support its growth.

在加拿大,WELL Health已成爲全國首個泛加拿大臨床網絡的領導者。此外,它實施了成本優化計劃,以提高運營效率和盈利能力。此外,WELL Health正在投資人工智能(AI)技術,開發將支持其增長的新產品。

No-brainer stock #3

毫無疑問的股票#3

Alimentation Couche-Tard (TSX:ATD) stock could be a solid addition to your portfolio. This company operates convenience stores, a defensive business known for its resilience and stability. The firm also engages in fuel retailing and provides electric vehicle (EV) charging.

Alimentation Couche-Tard(tsx:ATD)股票可能是你的投資組合的不錯選擇。該公司經營便利店業務,這是一個以其彈性和穩定性著稱的防禦性企業。該公司還從事燃油零售並提供電動汽車(EV)充電。

Couche-Tard has a proven track record of delivering robust earnings and consistently outperforming the broader market. Over the past decade, the companyâs adjusted EPS has grown at an impressive CAGR of 15.2%. This strong earnings growth has enabled the company to increase its dividends at a CAGR of 25.6% during the same period. Couche-Tard stock has grown at a CAGR of 16.6% over the last five years, translating into an overall capital gain of more than 115%.

Couche-Tard擁有提供強勁盈利和持續優於整個市場的記錄。在過去的十年中,該公司調整後每股收益以15.2%的CAGR增長。這種強勁的盈利增長使該公司能夠在同期內將其股息以25.6%的CAGR增長率提高。Couche-Tard股票在過去五年中以16.6%的CAGR增長,轉化爲總資本收益超過115%。

Couche-Tardâs extensive network of stores, the expansion of its private label products, and operating leverage will likely drive its financials. Furthermore, the companyâs solid balance sheet and ability to acquire and integrate companies will accelerate its growth rate and drive its share price and dividends.

Couche-Tard廣泛的商店網絡、私人標籤產品的擴展以及運營槓桿將推動其財務狀況。此外,該公司堅實的資產負債表以及收購和整合公司的能力將加速其增長率,並推動其股價和股息。

The post 3 No-Brainer Stocks to Buy With $300 Right Now appeared first on The Motley Fool Canada.

《財經郵報》加拿大版:300美元在眼前!這三隻毫無腦子的股票必須買!

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論